Cytokinetic investigation of lung tumors using the anti-bromodeoxyuridine (BUDR) monoclonal antibody method: Comparison with dna flow cytometric data-Reference-Cited by-同舟云学术

Cytokinetic investigation of lung tumors using the anti-bromodeoxyuridine (BUDR) monoclonal antibody method: Comparison with dna flow cytometric data

Published:1990-06-15 Issue:6 Volume:45 Page:995-1001
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Teodori Laura,Trinca Maria Luisa,Goehde Wolfgang,Hemmer Jorg,Salvati Franco,Storniello Giuseppe,Mauro Francesco

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference26 articles.

1. , , , , , , , , and , Cell kinetics of human brain tumors: in vivo study with bromodeoxyuridine and flow cytometry. Europ. J. Cancer Oncol., (1989) (In press).

2. New cell cycle compartments identified by multiparameter flow cytometry

3. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine.

4. The kinetics of cellular proliferation in normal and malignant tissues. V. Analysis of labeling indices and potential tissue doubling times in human tumor cell populations

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental and computational study on molecular structure and vibrational analysis of a modified biomolecule: 5-Bromo-2′-deoxyuridine;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2012-06

2. An Overview of Cancer Pathogenesis, Diagnosis, and Management;Tumors in Domestic Animals;2008-04-14

3. Parenteral Nutrition Does Not Stimulate Tumor Proliferation in Malnourished Gastric Cancer Patients;Journal of Parenteral and Enteral Nutrition;2007-11

4. Stratification of the biologic aggressiveness of non-small cell lung cancer using DNA flow cytometry and immunohistochemistry for the retinoblastoma protein;Lung Cancer;2004-09

5. Ability of bivariate cytokeratin and deoxyribonucleic acid flow cytometry to determine the biologic aggressiveness of resectable non–small cell lung cancer;The Journal of Thoracic and Cardiovascular Surgery;2002-08